CD229/SLAMF3/Lymphocyte Antigen 9 Antibody (312830) [DyLight 755]

• Reactivity: Mu
• Applications: WB, Flow, CyTOF-ready
• Clone: 312830
• Clonality: Monoclonal
• Host: Rat
• Conjugate: DyLight 755

CD229/SLAMF3/Lymphocyte Antigen 9 Antibody (312830) [DyLight 755] Summary

• Immunogen: Mouse myeloma cell line NS0-derived recombinant mouse CD229/SLAMF3
  Lys48-Phe454
  Accession # AAH95921
• Specificity: Detects mouse CD229/SLAMF3 in direct ELISAs and Western blots. In Western blots, no cross-reactivity with recombinant human CD229 is observed.
• Isotype: IgG2a
• Clonality: Monoclonal
• Host: Rat
• Gene: LY9
• Purity: Protein A or G purified from hybridoma culture supernatant

Applications/Dilutions

• Dilutions:
  • CyTOF-ready
  • Flow Cytometry
  • Western Blot
• Application Notes: Optimal dilution of this antibody should be experimentally determined.

Packaging, Storage & Formulations

• Storage: Store at 4C in the dark.
• Buffer: 50mM Sodium Borate
• Preservative: 0.05% Sodium Azide
• Purity: Protein A or G purified from hybridoma culture supernatant

Notes

DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.

Alternate Names for CD229/SLAMF3/Lymphocyte Antigen 9 Antibody (312830) [DyLight 755]

• CD229 antigen
• CD229
• cell-surface molecule Ly-9
• hly9
• Ly9
• lymphocyte antigen 9Cell surface molecule Ly-9
• mLY9
• SLAMF3
• T-lymphocyte surface antigen Ly-9

Background

LY9, also known as T-lymphocyte surface Antigen Ly-9, consists of four isoforms of sizes 72.1 kDa, 70.7 kDa, 57.3 kDa, and 72 kDa and interacts with adaptor molecules as an immunomodulatory receptor and member of the SLAM family. Current research is being conducted to identify the effect of the protein on diseases and disorders such as myeloma, hepatitis, lymphoproliferative syndrome, and dysgammaglobulinemia. The protein is involved in cell adhesion pathways with SH2D1A, AP2M1, PTPN11, GRB2, and SH2D1B proteins.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Bioinformatics

• Gene Symbol: LY9